文献速递免疫规划传染病防控与疫情报告

澳大利亚原住民儿童使用PHiD-CV10未改变无蛋白D基因的不可分型流感嗜血杆菌流行率

Use of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) in an Australian Indigenous paediatric population does not alter the prevalence of nontypeable Haemophilus influenzae without the protein D gene.
PubMed 文献 · Vaccine · 2019-06-01

本研究在澳大利亚北领地原住民婴幼儿中,比较PHiD-CV10疫苗使用前、中、后鼻咽和耳分泌物中不可分型流感嗜血杆菌(NTHi)hpd基因(编码蛋白D)的携带情况。结果显示各时期hpd#3-PCR阴性分离株比例无统计学显著差异,鼻咽和耳分泌物中分别总体7%和6%为阴性。基因组序列分析支持PCR结果,约7%的可获得基因组存在hpd基因截断。结论认为PHiD-CV10使用未选择出hpd-PCR阴性分离株。

要点

  • PHiD-CV10使用前后NTHi中hpd-PCR阴性分离株比例无显著变化。
  • 鼻咽和耳分泌物中hpd-PCR阴性NTHi分别约占7%和6%。
  • 约7%的可获得基因组存在hpd基因截断,与PCR结果一致。

核心结论

  • 在澳大利亚北领地原住民儿童中,使用PHiD-CV10未对hpd-PCR阴性NTHi分离株产生选择性。

研究设计与样本

  • 研究对PHiD-CV10使用前、中、后采集的鼻咽和耳分泌物NTHi分离株进行hpd基因PCR筛查,并分析基因组序列数据。

主要发现

  • 各时期hpd#3-PCR阴性分离株比例无统计学显著差异,鼻咽和耳分泌物中总体阴性率分别为7%和6%。
  • 核苷酸序列数据支持PCR findings,约7%的可获得基因组存在hpd基因截断,可能影响蛋白D表达。

临床怎么用

  • 在NTHi感染高风险的原住民儿童中,PHiD-CV10接种未增加无蛋白D基因NTHi的携带风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nontypeable Haemophilus influenzae (NTHi) is one of the main respiratory pathogens associated with otitis media and lung infections in Australian Indigenous children. PHiD-CV10, the 10-valent pneumococcal conjugate vaccine containing H. influenzae protein D was used in the Northern Territory infant vaccination schedule for two years from October 2009. METHODS: NTHi isolates from nasopharyngeal and ear discharge samples collected before, during and after the PHiD-CV10 era were screened for the hpd gene by PCR. Target amplicon sequence, extracted from available genomic sequence data, was analysed to identify variability in this region. RESULTS: There was no statistically significant difference in the proportion of hpd#3-PCR negative isolates from each era; overall 7% and 6% of nasopharyngeal and ear discharge isolates were negative, respectively. The nucleotide sequence data supported the hpd-PCR findings; truncations of the hpd gene precluding amplification and presumably expression of protein D were observed in approximately 7% of available genomes. CONCLUSIONS: In the Northern Territory of Australia, a population at high risk of NTHi-associated infection, PHiD-CV10 use did not select for hpd-PCR negative isolates.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Beissbarth J, Smith-Vaughan HC, Harris TM, et al. Use of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) in an Australian Indigenous paediatric population does not alter the prevalence of nontypeable Haemophilus influenzae without the protein D gene. Vaccine. 2019. PMID: 31164306. doi:10.1016/j.vaccine.2019.05.079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。